The spectrum of metabolic bone disease in lymphoblastic leukemia

31Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Eight patients with childhood acute lymphoblastic leukemia (ALL) and hypercalcemia, osteopenia, or vertebral compression fractures seen at our institution during the last 12 years were evaluated for biochemical evidence of bone disease. Five patients were hypercalcemic, three had abnormal phosphorous levels, and four had elevated alkaline phosphatase values. Parathyroid hormone (PTH) was measured by a polyvalent radioimmunoassay in five patients and these levels were abnormally high in three patients. Four of these five patients also had PTH measured by a midregion‐specific radioimmunoassay. One patient had a high PTH value. Two patients had low levels and one patient had a normal PTH level. Although these studies suggest diverse biochemical mechanisms may be contributing to the bone changes and hypercalcemia seen in childhood ALL, ectopic PTH production as well as ectopically produced fragments of PTH may have a role in mediating bone resorption and hypercalcemia. Cancer 59:346–350, 1987. Copyright © 1987 American Cancer Society

Cite

CITATION STYLE

APA

Cohn, S. L., Morgan, E. R., & Mallette, L. E. (1987). The spectrum of metabolic bone disease in lymphoblastic leukemia. Cancer, 59(2), 346–350. https://doi.org/10.1002/1097-0142(19870115)59:2<346::AID-CNCR2820590230>3.0.CO;2-I

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free